Lipocine Inc Cmn (LPCN) 3.37 $LPCN
DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses in Excess of $25,000 to Contact the Firm
ACCESSWIRE - Mon Aug 29, 8:14PM CDT
IRVINE, CA / ACCESSWIRE / August 29, 2016 / Khang & Khang LLP (the "Firm"
announces a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN). Investors, who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm by the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.37 (-0.17)
DEADLINE TOMORROW: The Law Offices of Vincent Wong Reminds Investors of a Class Action Lawsuit Involving Lipocine Inc. and a Lead Plaintiff Deadline of August 30, 2016 - LPCN
GlobeNewswire - Mon Aug 29, 10:07AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Lipocine Inc. (NASDAQ:LPCN) securities between June 30, 2015 and June 28, 2016.
LPCN: 3.37 (-0.17)
4-DAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Fri Aug 26, 2:03PM CDT
LOS ANGELES, CA / ACCESSWIRE / August 26, 2016 / Lundin Law PC (the "Firm" announces a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (Nasdaq: LPCN) concerning possible violations of federal securities laws between June 30, 2015 and June 28, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.37 (-0.17)
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lipocine, Inc. (LPCN) & Lead Plaintiff Deadline August 30, 2016
ACCESSWIRE - Fri Aug 26, 9:11AM CDT
NEW YORK, NY / ACCESSWIRE / August 26, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN) and certain of its officers. The class action was filed on behalf of a class consisting of all persons or entities who purchased Lipocine securities between June 30, 2015 through June 28, 2016, both dates inclusive (the "Class Period".
LPCN: 3.37 (-0.17)
6- DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE - Wed Aug 24, 2:33PM CDT
IRVINE, CA / ACCESSWIRE / August 24, 2016 / Khang & Khang LLP (the "Firm" announces a class action lawsuit was filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN). Investors, who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.37 (-0.17)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors in Lipocine Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 30, 2016 - LPCN
GlobeNewswire - Wed Aug 24, 8:25AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
LPCN: 3.37 (-0.17)
UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Mon Aug 22, 3:44PM CDT
LOS ANGELES, CA / ACCESSWIRE / August 22, 2016 / Lundin Law PC (the "Firm" announces that a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN) concerning possible violations of federal securities laws between June 30, 2015 and June 28, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.37 (-0.17)
SHAREHOLDER ALERT: Rosen Law Firm Reminds Lipocine Inc. Investors of Important August 30 Deadline in Class Action Filed by Firm - LPCN
GlobeNewswire - Mon Aug 22, 3:11PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Lipocine Inc. securities (NASDAQ:LPCN) from June 30, 2015 through June 28, 2016, inclusive (the "Class Period" of the important August 30, 2016 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for Lipocine investors under the federal securities laws.
LPCN: 3.37 (-0.17)
UPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE - Mon Aug 22, 10:01AM CDT
IRVINE, CA / ACCESSWIRE / August 22, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit was filed against Lipocine Inc. ("Lipocine" or the "Company" (Nasdaq: LPCN). Investors, who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.37 (-0.17)
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lipocine, Inc. (LPCN) & Lead Plaintiff Deadline: August 30, 2016
GlobeNewswire - Mon Aug 22, 9:00AM CDT
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company" (NASDAQ:LPCN) and certain of its officers. The class action was filed on behalf of a class consisting of all persons or entities who purchased Lipocine securities between June 30, 2015 through June 28, 2016, both dates inclusive (the "Class Period".
LPCN: 3.37 (-0.17)
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE - Thu Aug 18, 4:21PM CDT
IRVINE, CA / ACCESSWIRE / August 18, 2016 / Khang & Khang LLP (the "Firm" announces a class action lawsuit was filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN). Investors, who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.37 (-0.17)
DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Wed Aug 17, 10:55AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 17, 2016 / Lundin Law PC (the "Firm" announces that a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN) concerning possible violations of federal securities laws between June 30, 2015 and June 28, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.37 (-0.17)
Lundin Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE - Mon Aug 15, 10:36AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 15, 2016 / Lundin Law PC (the "Firm" announces a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN) concerning possible violations of federal securities laws between June 30, 2015 and June 28, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.37 (-0.17)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Lawsuit Involving Lipocine Inc. and a Lead Plaintiff Deadline of August 30, 2016
BusinessWire - Mon Aug 15, 9:50AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Lipocine Inc. (NASDAQ:LPCN) securities between June 30, 2015 and June 28, 2016.
LPCN: 3.37 (-0.17)
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lipocine, Inc. (LPCN) and Lead Plaintiff Deadline - August 30, 2016
ACCESSWIRE - Sun Aug 14, 9:39AM CDT
NEW YORK, NY / ACCESSWIRE / August 14, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN) and certain of its officers. The class action was filed on behalf of a class consisting of all persons or entities who purchased Lipocine securities between June 30, 2015 through June 28, 2016, both dates inclusive (the "Class Period".
LPCN: 3.37 (-0.17)
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Lipocine, Inc. (LPCN) & Lead Plaintiff Deadline: August 30, 2016
ACCESSWIRE - Thu Aug 11, 9:22AM CDT
NEW YORK, NY / ACCESSWIRE / August 11, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN) and certain of its officers. The class action was filed on behalf of a class consisting of all persons or entities who purchased Lipocine securities between June 30, 2015 through June 28, 2016, both dates inclusive (the "Class Period".
LPCN: 3.37 (-0.17)
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lipocine Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE - Wed Aug 10, 11:12AM CDT
IRVINE, CA / ACCESSWIRE / August 10, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit was filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN). Investors, who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.37 (-0.17)
DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses in Excess of $25,000 to Contact the Firm
ACCESSWIRE - Mon Aug 29, 8:14PM CDT
IRVINE, CA / ACCESSWIRE / August 29, 2016 / Khang & Khang LLP (the "Firm"
announces a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN). Investors, who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm by the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.37 (-0.17)
DEADLINE TOMORROW: The Law Offices of Vincent Wong Reminds Investors of a Class Action Lawsuit Involving Lipocine Inc. and a Lead Plaintiff Deadline of August 30, 2016 - LPCN
GlobeNewswire - Mon Aug 29, 10:07AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Lipocine Inc. (NASDAQ:LPCN) securities between June 30, 2015 and June 28, 2016.
LPCN: 3.37 (-0.17)
4-DAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Fri Aug 26, 2:03PM CDT
LOS ANGELES, CA / ACCESSWIRE / August 26, 2016 / Lundin Law PC (the "Firm"
announces a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (Nasdaq: LPCN) concerning possible violations of federal securities laws between June 30, 2015 and June 28, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.37 (-0.17)
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lipocine, Inc. (LPCN) & Lead Plaintiff Deadline August 30, 2016
ACCESSWIRE - Fri Aug 26, 9:11AM CDT
NEW YORK, NY / ACCESSWIRE / August 26, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company"
(NASDAQ: LPCN) and certain of its officers. The class action was filed on behalf of a class consisting of all persons or entities who purchased Lipocine securities between June 30, 2015 through June 28, 2016, both dates inclusive (the "Class Period". LPCN: 3.37 (-0.17)
6- DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE - Wed Aug 24, 2:33PM CDT
IRVINE, CA / ACCESSWIRE / August 24, 2016 / Khang & Khang LLP (the "Firm"
announces a class action lawsuit was filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN). Investors, who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.37 (-0.17)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors in Lipocine Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 30, 2016 - LPCN
GlobeNewswire - Wed Aug 24, 8:25AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
LPCN: 3.37 (-0.17)
UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Mon Aug 22, 3:44PM CDT
LOS ANGELES, CA / ACCESSWIRE / August 22, 2016 / Lundin Law PC (the "Firm"
announces that a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN) concerning possible violations of federal securities laws between June 30, 2015 and June 28, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.37 (-0.17)
SHAREHOLDER ALERT: Rosen Law Firm Reminds Lipocine Inc. Investors of Important August 30 Deadline in Class Action Filed by Firm - LPCN
GlobeNewswire - Mon Aug 22, 3:11PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Lipocine Inc. securities (NASDAQ:LPCN) from June 30, 2015 through June 28, 2016, inclusive (the "Class Period"
of the important August 30, 2016 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for Lipocine investors under the federal securities laws. LPCN: 3.37 (-0.17)
UPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE - Mon Aug 22, 10:01AM CDT
IRVINE, CA / ACCESSWIRE / August 22, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit was filed against Lipocine Inc. ("Lipocine" or the "Company" (Nasdaq: LPCN). Investors, who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.37 (-0.17)
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lipocine, Inc. (LPCN) & Lead Plaintiff Deadline: August 30, 2016
GlobeNewswire - Mon Aug 22, 9:00AM CDT
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company"
(NASDAQ:LPCN) and certain of its officers. The class action was filed on behalf of a class consisting of all persons or entities who purchased Lipocine securities between June 30, 2015 through June 28, 2016, both dates inclusive (the "Class Period". LPCN: 3.37 (-0.17)
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE - Thu Aug 18, 4:21PM CDT
IRVINE, CA / ACCESSWIRE / August 18, 2016 / Khang & Khang LLP (the "Firm"
announces a class action lawsuit was filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN). Investors, who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.37 (-0.17)
DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Wed Aug 17, 10:55AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 17, 2016 / Lundin Law PC (the "Firm"
announces that a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN) concerning possible violations of federal securities laws between June 30, 2015 and June 28, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.37 (-0.17)
Lundin Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE - Mon Aug 15, 10:36AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 15, 2016 / Lundin Law PC (the "Firm"
announces a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN) concerning possible violations of federal securities laws between June 30, 2015 and June 28, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.37 (-0.17)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Lawsuit Involving Lipocine Inc. and a Lead Plaintiff Deadline of August 30, 2016
BusinessWire - Mon Aug 15, 9:50AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Lipocine Inc. (NASDAQ:LPCN) securities between June 30, 2015 and June 28, 2016.
LPCN: 3.37 (-0.17)
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lipocine, Inc. (LPCN) and Lead Plaintiff Deadline - August 30, 2016
ACCESSWIRE - Sun Aug 14, 9:39AM CDT
NEW YORK, NY / ACCESSWIRE / August 14, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company"
(NASDAQ: LPCN) and certain of its officers. The class action was filed on behalf of a class consisting of all persons or entities who purchased Lipocine securities between June 30, 2015 through June 28, 2016, both dates inclusive (the "Class Period". LPCN: 3.37 (-0.17)
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Lipocine, Inc. (LPCN) & Lead Plaintiff Deadline: August 30, 2016
ACCESSWIRE - Thu Aug 11, 9:22AM CDT
NEW YORK, NY / ACCESSWIRE / August 11, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company"
(NASDAQ: LPCN) and certain of its officers. The class action was filed on behalf of a class consisting of all persons or entities who purchased Lipocine securities between June 30, 2015 through June 28, 2016, both dates inclusive (the "Class Period". LPCN: 3.37 (-0.17)
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lipocine Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE - Wed Aug 10, 11:12AM CDT
IRVINE, CA / ACCESSWIRE / August 10, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit was filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN). Investors, who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.37 (-0.17)
